SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-19-028475
Filing Date
2019-05-28
Accepted
2019-05-28 17:26:35
Documents
7
Period of Report
2019-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tv522531_6k.htm 6-K 11610
2 EXHIBIT 99.1 tv522531_ex99-1.htm EX-99.1 8067
3 EXHIBIT 99.2 tv522531_ex99-2.htm EX-99.2 157512
4 EXHIBIT 99.3 tv522531_ex99-3.htm EX-99.3 5312
5 GRAPHIC tv522531_ex99-2img01.jpg GRAPHIC 9859
6 GRAPHIC tv522531_ex99-3img01.jpg GRAPHIC 106498
7 GRAPHIC tv522531_ex99-3img02.jpg GRAPHIC 69175
  Complete submission text file 0001144204-19-028475.txt   431451
Mailing Address 1/3 HIGH-TECH VILLAGE GIVAT RAM, P.0. BOX 39264 JERUSALEM L3 9139102
Business Address 1/3 HIGH-TECH VILLAGE GIVAT RAM, P.0. BOX 39264 JERUSALEM L3 9139102 972-2-5486555
Anchiano Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38807 | Film No.: 19858773
SIC: 2834 Pharmaceutical Preparations